Factors Associated with Viral Suppression Among Adolescents on Antiretroviral Therapy in Homa Bay County, Kenya: A Retrospective Cross-Sectional Study

References

• UNAIDS. Ending the AIDS epidemic for adolescents, with adolescents: a practical guide to meaningfully engage adolescents in the AIDS response,2016. Available from: http://www.unaids.org/en/resources/documents/2016/ending-AIDS-epidemic-adolescents. Accessed December 15, 2021.
   Google Scholar
• Ministry of Health. Kenya HIV estimates 2015. Nairobi, Kenya, 2016. Available from: https://nacc.or.ke/…/uploads/2016/12/Kenya-HIV-Estimates-2015.pdf. Accessed December 15, 2021.
   Google Scholar
• UNAIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. 2017. Available from: http://www.unaids.org/sites/default/files/media_asset/90-90-90_en.pdf. Accessed September 20, 2017.
   Google Scholar
• World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection, Recommendations for a Public Health Approach; 2016 [cited January 10, 2016]. Available from: http://www.who.Int/hiv/pub/arv/arv-2016/en/. Accessed December 15, 2021.
   Google Scholar
• World Health Organization. Progress report 2016: prevent HIV, test and treat all. WHO support for country impact, 2017. Available from: http://www.who.int/hiv/pub/progressreports/2016-progress-report/en/. Accessed December 15, 2021.
   Google Scholar
• Onsongo S, Abidi SH, Khamadi S, et al. Prevalence of transmitted drug resistance mutations in HIV-1-infected drug-naive patients from urban and suburban regions of Kenya. AIDS Res Hum Retroviruses. 2016;32(3):220–225. doi:10.1089/aid.2015.0026
   Web of Science ®Google Scholar
• Silverman RA, Beck IA, Kiptinness C, et al. Prevalence of pre-antiretroviral-treatment drug resistance by gender, age, and other factors in HIV-infected individuals initiating therapy in Kenya, 2013–2014. J Infect Dis. 2017;216(12):1569–1578. doi:10.1093/infdis/jix544
   Web of Science ®Google Scholar
• Ministry of Health. Guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, Nairobi, Kenya, 2017. Available from: https://www.nascop.or.ke/?page_id=2411. Accessed December 15, 2021.
   Google Scholar
• Cohen MS, Smith MK, Muessig KE, et al. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet. 2013;382(9903):1515–1524. doi:10.1016/S0140-6736(13)61998-4
   PubMed Web of Science ®Google Scholar
• Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30. doi:10.7326/0003-4819-133-1-200007040-00004
   PubMed Web of Science ®Google Scholar
• Hanghøj S, Boisen KA. Self-reported barriers to medication adherence among chronically ill adolescents: a systematic review. J Adolesc Health. 2014;54(2):121–138. doi:10.1016/j.jadohealth.2013.08.009
   PubMed Web of Science ®Google Scholar
• Evans D, Menezes C, Mahomed K, et al. Treatment outcomes of HIV-infected adolescents attending public-sector HIV clinics across Gauteng and Mpumalanga, South Africa. AIDS Res Hum Retroviruses. 2013;29(6):892–900. doi:10.1089/AID.2012.0215
   PubMed Web of Science ®Google Scholar
• Nglazi MD, Kranzer K, Holele P, et al. Treatment outcomes in HIV-infected adolescents attending a community-based antiretroviral therapy clinic in South Africa. BMC Infect Dis. 2012;12(1):21. doi:10.1186/1471-2334-12-21
   PubMed Web of Science ®Google Scholar
• Kamya MR, Mayanja-Kizza H, Kambugu A, et al. Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;46(2):187–193. doi:10.1097/QAI.0b013e31814278c0
   PubMed Web of Science ®Google Scholar
• Ministry of Health. The Kenya AIDS indicator survey. Nairobi, Kenya, 2012. Available from: https://nacc.or.ke/kais-2012-final-report/. Accessed December 15, 2021.
   Google Scholar
• Bunupuradah T, Sricharoenchai S, Hansudewechakul R, et al. Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents. Pediatr Infect Dis J. 2015;34(3):e58–e62. doi:10.1097/INF.0000000000000584
   PubMed Web of Science ®Google Scholar
• Muri L, Gamell A, Ntamatungiro AJ, et al. Development of HIV drug resistance and therapeutic failure in children and adolescents in rural Tanzania: an emerging public health concern. AIDS. 2017;31(1):61–70. doi:10.1097/QAD.0000000000001273
   PubMed Web of Science ®Google Scholar
• Makadzange AT, Higgins-Biddle M, Chimukangara B, et al. Clinical, virologic, immunologic outcomes and emerging HIV drug resistance patterns in children and adolescents in public ART care in Zimbabwe. PLoS One. 2015;10(12):e0144057. doi:10.1371/journal.pone.0144057
   PubMed Web of Science ®Google Scholar
• Jobanputra K, Parker LA, Azih C, et al. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS One. 2015;10(2):e0116144. doi:10.1371/journal.pone.0116144
   PubMed Web of Science ®Google Scholar
• Bulage L, Ssewanyana I, Nankabirwa V, et al. Factors associated with virological non-suppression among HIV-positive patients on antiretroviral therapy in Uganda, August 2014-July 2015. BMC Infect Dis. 2017;17(1):326. doi:10.1186/s12879-017-2428-3
   PubMed Web of Science ®Google Scholar
• Kipp W, Alibhai A, Saunders LD, et al. Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda. AIDS Care. 2010;22(3):271–278. doi:10.1080/09540120903193625
   PubMed Web of Science ®Google Scholar
• Huong DT, Bannister W, Phong PT, et al. Factors associated with HIV-1 virological failure in an outpatient clinic for HIV-infected people in Haiphong, Vietnam. Int J STD AIDS. 2011;22(11):659–664. doi:10.1258/ijsa.2011.010515
   Web of Science ®Google Scholar
• Fenner L, Atkinson A, Boulle A, et al. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies. J Int AIDS Soc. 2017;20(1):21327. doi:10.7448/IAS.20.1.21327
   Web of Science ®Google Scholar
• Davey JD, Abrahams Z, Feinberg M, et al. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa. Int J STD AIDS. 2018;29(6):603–610. doi:10.1177/0956462417748859
   Web of Science ®Google Scholar
• Ramadhani HO, Bartlett JA, Thielman NM, et al. Association of first-line and second-line antiretroviral therapy adherence. Open Forum Infect Dis. 2014;1(2):ofu079. doi:10.1093/ofid/ofu079
   Google Scholar
• Bernheimer JM, Patten G, Makeleni T, et al. Paediatric HIV treatment failure: a silent epidemic. J Int AIDS Soc. 2015;18(1):20090. doi:10.7448/IAS.18.1.20090
   PubMed Web of Science ®Google Scholar
• Inzaule SC, Hamers RL, Kityo C, et al. Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: a qualitative study. PLoS One. 2016;11(11):e0167492. doi:10.1371/journal.pone.0167492
   PubMed Web of Science ®Google Scholar
• Sithole Z, Mbizvo E, Chonzi P, et al. Virological failure among adolescents on ART, Harare City, 2017- A case-control study. BMC Infect Dis. 2018;18(1):469. doi:10.1186/s12879-018-3372-6
   PubMed Web of Science ®Google Scholar
• Ugwu R, Eneh A. Factors influencing adherence to paediatric antiretroviral therapy in Portharcourt, South- South Nigeria. Pan Afr Med J. 2013;16:30. doi:10.11604/pamj.2013.16.30.1877
   Google Scholar
• Xu L, Munir K, Kanabkaew C, Le Coeur S, Thorne C. Factors influencing antiretroviral treatment suboptimal adherence among perinatally HIV-infected adolescents in Thailand. PLoS One. 2017;12(2):e0172392. doi:10.1371/journal.pone.0172392
   PubMed Web of Science ®Google Scholar